Why Repligen (RGEN) Shares Are Sliding Today [Yahoo! Finance]
Repligen Corporation (RGEN)
Last repligen corporation earnings: 2/20 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
repligen.com/investors
Company Research
Source: Yahoo! Finance
During the event, President and CEO Olivier Loeillot stated that at the midpoint of the company's guidance, 2025 sales were $733 million. Repligen, which described itself as a 'pure bioprocessing play,' focuses on creating materials used in the manufacturing of biologic drugs. The negative stock reaction suggested investors may have been underwhelmed by the sales forecast, potentially expecting a more robust outlook for the year ahead. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Repligen? Access our full analysis report here, it's free Repligen's shares are very volatile and have had 24 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The biggest move we wrote about over the last year was 6 months ago when the stock gained 7.8% on
Show less
Read more
Impact Snapshot
Event Time:
RGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RGEN alerts
High impacting Repligen Corporation news events
Weekly update
A roundup of the hottest topics
RGEN
News
- Repligen (NASDAQ:RGEN) was upgraded by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from a "sell (d+)" rating to a "hold (c-)" rating.MarketBeat
- Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair [Yahoo! Finance]Yahoo! Finance
- Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected ChairGlobeNewswire
- Repligen (NASDAQ:RGEN) had its "sell (d+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Repligen Corporation to Present at J.P. Morgan 2026 Healthcare ConferenceGlobeNewswire
RGEN
Earnings
- 10/28/25 - Beat
RGEN
Sec Filings
- 1/12/26 - Form 4
- 1/12/26 - Form 3
- 1/6/26 - Form 8-K
- RGEN's page on the SEC website